{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:51:26Z","timestamp":1793116286969,"version":"4.5.0"},"reference-count":102,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MASE_Regione Campania","award":["CUP_ B21I22000180001"],"award-info":[{"award-number":["CUP_ B21I22000180001"]}],"id":[{"id":"https:\/\/ror.org\/02kg21794","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cardiometabolic diseases, including cardiovascular disorders and type 2 diabetes mellitus, are the leading cause of morbidity and mortality worldwide, placing a significant burden on healthcare systems. Although advances in imaging and risk stratification have improved disease management, conventional diagnostic and prognostic tools often lack the requisite sensitivity and specificity for early and precise risk stratification. This limitation stems from their poor ability to capture the full molecular complexity of these conditions, underscoring an urgent need for innovative biomarkers to bridge these gaps. MicroRNAs, small non-coding RNAs that regulate gene expression post-transcriptionally, have emerged as promising candidates. Their characteristics offer several advantages over traditional methods, including exceptional stability in biological fluids, strong tissue and disease specificity, and the ability to reflect dynamic pathological changes. These unique features enable miRNAs to detect subtle molecular alterations that may precede clinical symptoms, thereby overcoming key limitations of current diagnostic approaches. Altered circulating miRNA profiles have been linked to pathological processes such as endothelial dysfunction, inflammation, oxidative stress, and maladaptive cardiac remodeling. This review provides a comprehensive overview of the current evidence supporting the diagnostic and prognostic role of circulating miRNAs in cardiometabolic disease. We highlight their potential as early detection biomarkers, tools for patient stratification, and indicators of therapeutic response. Furthermore, we discuss key limitations to clinical translation, including methodological variability, challenges in sample handling, differences in normalization strategies, and platform-dependent quantification inconsistencies. Overcoming these obstacles and achieving robust large-scale clinical validation will be essential to fully harness the potential of miRNAs as next-generation molecular signatures in precision medicine.<\/jats:p>","DOI":"10.3390\/ijms262110769","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:09:47Z","timestamp":1762358987000},"page":"10769","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["MicroRNA Signatures in Cardiometabolic Disorders as a Next-Generation Diagnostic Approach: Current Insight"],"prefix":"10.3390","volume":"26","author":[{"given":"Concetta","family":"Iside","sequence":"first","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6509-9789","authenticated-orcid":false,"given":"Francesca","family":"Picone","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-1961","authenticated-orcid":false,"given":"Paola","family":"Di Pietro","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2811-8018","authenticated-orcid":false,"given":"Angela Carmelita","family":"Abate","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2380-1611","authenticated-orcid":false,"given":"Valeria","family":"Prete","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0258-5324","authenticated-orcid":false,"given":"Antonio","family":"Damato","sequence":"additional","affiliation":[{"name":"Vascular Physiopathology Unit, IRCCS Neuromed, 86077 Pozzilli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Venturini","sequence":"additional","affiliation":[{"name":"Vascular Physiopathology Unit, IRCCS Neuromed, 86077 Pozzilli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Akeel","sequence":"additional","affiliation":[{"name":"Department of Drug and Health Sciences, University of Catania, Via Santa Sofia 64, 95125 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5692-1130","authenticated-orcid":false,"given":"Salvatore","family":"Petralia","sequence":"additional","affiliation":[{"name":"Department of Drug and Health Sciences, University of Catania, Via Santa Sofia 64, 95125 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Vecchione","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"},{"name":"Vascular Physiopathology Unit, IRCCS Neuromed, 86077 Pozzilli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2689-0008","authenticated-orcid":false,"given":"Albino","family":"Carrizzo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"},{"name":"Vascular Physiopathology Unit, IRCCS Neuromed, 86077 Pozzilli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Eroglu, T., Capone, F., and Schiattarella, G.G. (2024). The evolving landscape of cardiometabolic diseases. EBioMedicine, 109.","DOI":"10.1016\/j.ebiom.2024.105447"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e70878","DOI":"10.1002\/hsr2.70878","article-title":"Advancements in Biomarkers for Early Detection and Risk Stratification of Cardiovascular Diseases-A Literature Review","volume":"8","author":"Nazir","year":"2025","journal-title":"Health Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1124\/jpet.121.001152","article-title":"The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments","volume":"384","author":"Wronska","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1002\/ehf2.14523","article-title":"MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy","volume":"10","author":"Aleshcheva","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/nar\/gkad1142","article-title":"The miRNA-target interactions: An underestimated intricacy","volume":"52","author":"Diener","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCRESAHA.114.300645","article-title":"MicroRNA control of high-density lipoprotein metabolism and function","volume":"114","author":"Rayner","year":"2014","journal-title":"Circ. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.biopha.2018.03.173","article-title":"Microrna-145 accelerates the inflammatory reaction through activation of NF-\u03baB signaling in atherosclerosis cells and mice","volume":"103","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wang, D.A.-O., and Atanasov, A.A.-O. (2019). The microRNAs Regulating Vascular Smooth Muscle Cell Proliferation: A Minireview. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020324"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"108416","DOI":"10.1016\/j.clineuro.2024.108416","article-title":"The role of microRNAs as super-early biomarkers in acute ischemic stroke: A systematic review","volume":"244","author":"Loggini","year":"2024","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shi, Y., Tian, T., Cai, E.L., Yang, C., and Yang, X. (2021). miR-214 Alleviates Ischemic Stroke-Induced Neuronal Death by Targeting DAPK1 in Mice. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.745087"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"12446","DOI":"10.1523\/JNEUROSCI.1641-15.2015","article-title":"In Vivo Inhibition of miR-155 Promotes Recovery after Experimental Mouse Stroke","volume":"35","author":"Lordkipanidze","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12974-017-0819-4","article-title":"Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury","volume":"14","author":"Kumar","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/bs.apcsb.2022.10.008","article-title":"Emerging role of heat shock proteins in cardiovascular diseases","volume":"134","author":"Hazra","year":"2023","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Popat, A., Jnaneswaran, G., Yerukala Sathipati, S., and Sharma, P.P. (2025). MicroRNAs in cardiac arrhythmias: Mechanisms, biomarkers, and therapeutic frontiers. Heart Rhythm, in press.","DOI":"10.1016\/j.hrthm.2025.05.052"},{"key":"ref_15","first-page":"1002","article-title":"miRNA-miRNA crosstalk: From genomics to phenomics","volume":"18","author":"Xu","year":"2017","journal-title":"Brief. Bioinform."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Naderi Yeganeh, P., Teo, Y.Y., Karagkouni, D., Pita-Ju\u00e1rez, Y., Morgan, S.L., Slack, F.J., Vlachos, I.S., and Hide, W.A. (2023). PanomiR: A systems biology framework for analysis of multi-pathway targeting by miRNAs. Brief. Bioinform., 46.","DOI":"10.1101\/2022.07.12.499819"},{"key":"ref_17","first-page":"36","article-title":"Recent progress in miRNA biogenesis and decay","volume":"21","year":"2023","journal-title":"RNA Biol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hynes, C., and Kakumani, P.K. (2024). Regulatory role of RNA-binding proteins in microRNA biogenesis. Front. Mol. Biosci., 11.","DOI":"10.3389\/fmolb.2024.1374843"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e1680","DOI":"10.1002\/wrna.1680","article-title":"Biogenesis, characterization, and functions of mirtrons","volume":"13","author":"Salim","year":"2021","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1093\/eurheartj\/ehad662","article-title":"4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification","volume":"44","author":"Kiyuna","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Fumarulo, I.A.-O., De Prisco, A., Salerno, E.N.M., Ravenna, S.A.-O., Vaccarella, M.A.-O., Garramone, B.A.-O.X., Burzotta, F.A.-O., and Aspromonte, N. (2025). New Frontiers of microRNA in Heart Failure: From Clinical Risk to Therapeutic Applications. J. Clin. Med., 14.","DOI":"10.3390\/jcm14186361"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCRESAHA.107.153916","article-title":"Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis","volume":"101","author":"Kuehbacher","year":"2007","journal-title":"Circ. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Braun, H., Hauke, M., Ripperger, A., Ihling, C., Fuszard, M., Eckenstaler, R.A.-O., and Benndorf, R.A.-O. (2021). Impact of DICER1 and DROSHA on the Angiogenic Capacity of Human Endothelial Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189855"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1373\/clinchem.2018.300061","article-title":"High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction","volume":"65","author":"Boeddinghaus","year":"2019","journal-title":"Clin. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCHEARTFAILURE.113.000266","article-title":"MicroRNAs in heart failure: Is the picture becoming less miRky?","volume":"7","author":"Melman","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wang, X., Lu, Y., Zhao, R., Zhu, B., Liu, J., Yue, Q., Wu, R., Han, S., Gao, Y., and Chen, J. (2024). Global surveillance of circulating microRNA for diagnostic and prognostic assessment of acute myocardial infarction based on the plasma small RNA sequencing. Biomark. Res., 12.","DOI":"10.1186\/s40364-024-00690-x"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s41065-025-00519-z","article-title":"Suppression of circ_0091761 ameliorates acute myocardial infarction-induced endothelial injury through regulation of miR-1278","volume":"162","author":"Zhou","year":"2025","journal-title":"Hereditas"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s13019-025-03518-3","article-title":"Study on the mechanism and clinical value of miR-210-3p and miR-582-5p in acute myocardial infarction by targeting MXD1","volume":"20","author":"Liu","year":"2025","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s11845-020-02196-5","article-title":"High level of circulating microRNA-142 is associated with acute myocardial infarction and reduced survival","volume":"189","author":"Guo","year":"2020","journal-title":"Ir. J. Med. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zhou, P., Zhang, J., Wu, X., Zhang, L., Liu, Q., Xiong, R., Wang, Y., Li, M., Wei, R., and Xu, X. (Int. J. Leg. Med., 2025). Differential diagnosis of acute myocardial infarction based on plasma Exosomal MicroRNA, Int. J. Leg. Med., ahead of print.","DOI":"10.1007\/s00414-025-03583-2"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Li, G., Zhao, J., Zhou, Z., Xu, W., Wang, S., and Sun, Q. (2025). Circulating microRNA-1 as a diagnostic biomarker for acute myocardial infarction: A meta-analysis. Cardiol. J., ahead of print.","DOI":"10.5603\/cj.100348"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"113989","DOI":"10.1016\/j.jconrel.2025.113989","article-title":"Adipose stem cell-derived nanovesicles for cardioprotection: Production and identification of therapeutic components","volume":"385","author":"Huang","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Fu, X., Zhang, X., Wang, L., Zhang, J., Li, W., Qin, S., Zhang, M., Zheng, X., Li, Y., and Yang, S. (2025). The potential value of microRNA-409-5p-mediated negative regulation of USP7 in the diagnosis and treatment of acute myocardial infarction. BMC Cardiovasc. Disord., 25.","DOI":"10.1186\/s12872-025-04590-2"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zhang, P., Liang, T., Chen, Y., Wang, X., Wu, T., Xie, Z., Luo, J., Yu, Y.A.-O.X., and Yu, H.A.-O. (2020). Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease. BioMed Res. Int., 2020.","DOI":"10.1155\/2020\/3593962"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jfma.2024.01.019","article-title":"Association of exosomes in patients with compromised myocardial perfusion on functional imaging","volume":"123","author":"Liu","year":"2024","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cui, F., Chen, W., Wang, P., Fan, J., Si, D., Ma, Q., Shi, J., and He, Y. (2024). Gold metallene-based ECL biosensor to detect miRNA-126 for coronary artery calcification diagnosis. Biosens. Bioelectron., 271.","DOI":"10.1016\/j.bios.2024.116993"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e26960","DOI":"10.1016\/j.heliyon.2024.e26960","article-title":"Decreased plasma miR-140-3p is associated with coronary artery disease","volume":"10","author":"Mo","year":"2024","journal-title":"Heliyon"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kana\u0161niece, E., Dauk\u0161aite, V., Vilne, B., Gail\u012bte, L., Caun\u012bte, L., \u0112rglis, A., and Tru\u0161inskis, K. (2025). Circulating plasma microRNA expression profile: Potential minimally invasive biomarker for early detection of coronary artery disease development. Mol. Biol. Rep., 52.","DOI":"10.1007\/s11033-025-11060-7"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Choudhury, R.R., Gupta, H., Bhushan, S., Singh, A., Roy, A., and Saini, N. (2024). Role of miR-128-3p and miR-195-5p as biomarkers of coronary artery disease in Indians: A pilot study. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-61077-4"},{"key":"ref_40","first-page":"325","article-title":"Circulating miRNA-106b-5p As a Potential Biomarker for Coronary Artery Disease","volume":"13","author":"Shabani","year":"2024","journal-title":"Int. J. Mol. Cell. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Makarenkov, N.A.-O.X., Yoel, U.A.-O., Haim, Y., Pincu, Y.A.-O., Bhandarkar, N.A.-O., Shalev, A., Shelef, I.A.-O., Liberty, I.F., Ben-Arie, G., and Yardeni, D. (2024). Circulating isomiRs May Be Superior Biomarkers Compared to Their Corresponding miRNAs: A Pilot Biomarker Study of Using isomiR-Ome to Detect Coronary Calcium-Based Cardiovascular Risk in Patients with NAFLD. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020890"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Iusupova, A.A.-O., Pakhtusov, N.A.-O., Slepova, O.A.-O., Khabarova, N.V., Privalova, E.V., Bure, I.V., Nemtsova, M.V., and Belenkov, Y.A.-O. (2024). MiRNA-34a, miRNA-145, and miRNA-222 Expression, Matrix Metalloproteinases, TNF-\u03b1 and VEGF in Patients with Different Phenotypes of Coronary Artery Disease. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202411.1329.v1"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Pe\u00f1a-Pe\u00f1a, M.A.-O., Zepeda-Garc\u00eda, \u00d3.A.-O., Posadas-S\u00e1nchez, R.A.-O., S\u00e1nchez-Mu\u00f1oz, F.A.-O., Dom\u00ednguez-P\u00e9rez, M.A.-O., Mart\u00ednez-Greene, J.A.-O.X., L\u00f3pez-Bautista, F.A.-O., Hern\u00e1ndez-D\u00edazcouder, A.A.-O., Jim\u00e9nez-Ortega, R.F., and Valencia-Cruz, A.I. (2025). A Plasma Extracellular Vesicle-Derived microRNA Signature as a Potential Biomarker for Subclinical Coronary Atherosclerosis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178727"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mir, R.A.-O., Elfaki, I.A.-O.X., Khullar, N., Waza, A.A., Jha, C.A.-O., Mir, M.A.-O., Nisa, S., Mohammad, B., Mir, T.A., and Maqbool, M. (2021). Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis. J. Cardiovasc. Dev. Dis., 8.","DOI":"10.3390\/jcdd8020022"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00380-024-02410-9","article-title":"Plasma microRNA-143 and microRNA-145 levels are elevated in patients with left ventricular dysfunction","volume":"39","author":"Murase","year":"2024","journal-title":"Heart Vessels"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11883-025-01309-8","article-title":"Global Perspectives on Coronary Artery Disease: The Emerging Role of miRNAs","volume":"27","author":"Mansour","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12265-025-10625-y","article-title":"The Clinical Significance of miR-139-5p in Acute Coronary Syndrome and its Potential Effect on the Progression of Acute Coronary Syndrome","volume":"18","author":"Wang","year":"2025","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhao, N., Na, K., Sun, W., Shi, H., Zhang, X., Liu, B., and Han, Y. (2025). Plasma microRNA-210 is associated with VEGF-A and EphrinA3 and relates to coronary collateral circulation in patients with coronary heart disease: A cross-sectional study. BMC Cardiovasc. Disord., 25.","DOI":"10.1186\/s12872-025-05013-y"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12933-024-02142-0","article-title":"Circulating exosomal mir-16-2-3p is associated with coronary microvascular dysfunction in diabetes through regulating the fatty acid degradation of endothelial cells","volume":"23","author":"Liu","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s40200-024-01391-w","article-title":"Altered expression of miR-375 and miR-541 in type 2 diabetes patients with and without coronary artery disease (CAD): The potential of miR-375 as a CAD biomarker","volume":"23","author":"Sangali","year":"2024","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"156938","DOI":"10.1016\/j.cyto.2025.156938","article-title":"LINC00426 promotes the progression of atherosclerosis by regulating miR-873-5p\/SRRM2 axis","volume":"191","author":"Zhou","year":"2025","journal-title":"Cytokine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1002\/ehf2.15324","article-title":"Multi-microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings","volume":"12","author":"Parvan","year":"2025","journal-title":"ESC Heart Fail."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Parvan, R., Becker, V., Hosseinpour, M., Moradi, Y., Louch, W.E., Cataliotti, A., Devaux, Y., Frisk, M., and Silva, G.J.J. (2025). Prognostic and predictive microRNA panels for heart failure patients with reduced or preserved ejection fraction: A meta-analysis of Kaplan-Meier-based individual patient data. BMC Med., 23.","DOI":"10.1186\/s12916-025-04238-0"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Evin, L., Sigutova, R., Sulc, P., Kufova, E., Branny, M., Vaclavik, J., and Stejskal, D. (2025). Serum levels of miR-21, miR-23a, miR-142-5p, and miR-126 in chronic failure with reduced ejection fraction: A case-control study. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1529451"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"106123","DOI":"10.4330\/wjc.v17.i5.106123","article-title":"Circulating microRNAs in predicting fibrosis in hypertrophic cardiomyopathy: A systematic review","volume":"17","author":"Mylavarapu","year":"2025","journal-title":"World J. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Alcibahy, Y., Darwish, R., Abu-Sharia, G., Maes, Q., and Elgamassy, O. (2025). Circulating microRNAs as biomarkers for ischemic heart disease: A systematic review and gene set enrichment analysis. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1545023"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Grimaldi, A.A.-O., D\u2019Assante, R.A.-O.X., Fiore, F.A.-O., Marcella, S.A.-O., Paolillo, S., Cacciatore, F., Mercurio, V.A.-O., Bossone, E.A.-O., Cittadini, A., and Tocchetti, C.A.-O.X. (2025). Circulating miR-10b-5p, miR-193a-3p, and miR-1-3p Are Deregulated in Patients with Heart Failure and Correlate with Hormonal Deficiencies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26115225"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41387-025-00362-1","article-title":"MiRNAs as biomarkers of nutritional therapy to achieve T2DM remission in patients with coronary heart disease: From the CORDIOPREV study","volume":"15","author":"Camargo","year":"2025","journal-title":"Nutr. Diabetes"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12933-024-02374-0","article-title":"Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: A case-control study","volume":"23","author":"Czop","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12933-024-02331-x","article-title":"Endothelial microRNAs in INOCA patients with diabetes mellitus","volume":"23","author":"Ferrone","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_61","first-page":"151367","article-title":"miR378a-3p in serum extracellular vesicles is associated with pancreatic beta-cell mass in diabetic states","volume":"750","author":"Yokoi","year":"2025","journal-title":"Res. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Yang, S., Wang, M., and Deng, Q. (2025). Circulating miR-4454 as a potential biomarker for the diagnosis of T2DM and the prediction value of comorbidity and complications in T2DM. BMC Endocr. Disord., 25.","DOI":"10.1186\/s12902-025-01964-7"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Yin, R., Zhang, Y., Fang, X., Zhang, Y., Miao, R., Yao, Y., Guan, H., and Tian, J. (2025). Discovering diabetes complications-related microRNAs: Meta-analyses and pathway modeling approach. BMC Med. Genom., 18.","DOI":"10.1186\/s12920-025-02144-1"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Hamdy, S.M., Ibrahim, H.A., Abdelaleem, O.A.-O., Shaker, O.G., Hussein, S.K., Massoud, S., and Sayed, O.N. (2025). MALAT1 SNP (rs619586) shows a protective effect against type 1 diabetes mellitus, while the miR-146a SNP (rs57095329) is linked to an increased risk of developing the disease. Mol. Biol. Rep., 52.","DOI":"10.1007\/s11033-025-10404-7"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41591-025-03730-7","article-title":"A microRNA-based dynamic risk score for type 1 diabetes","volume":"31","author":"Joglekar","year":"2025","journal-title":"Nat. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0194-y","article-title":"A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: From the CORDIOPREV study","volume":"50","author":"Camargo","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Swolin-Eide, D.A.-O., Forsander, G.A.-O., Pundziute Lyck\u00e5, A.A.-O., Novak, D.A.-O., Grillari, J.A.-O., Diendorfer, A.A.-O., Hackl, M.A.-O., and Magnusson, P.A.-O. (2023). Circulating microRNAs in young individuals with long-duration type 1 diabetes in comparison with healthy controls. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-38615-7"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12933-020-01107-3","article-title":"MicroRNAs and obesity-induced endothelial dysfunction: Key paradigms in molecular therapy","volume":"19","author":"Nguyen","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"120304","DOI":"10.1016\/j.cca.2025.120304","article-title":"The role of miR-21 as a biomarker and therapeutic target in cardiovascular disease","volume":"574","author":"He","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Zapata-Mart\u00ednez, L., \u00c1guila, S., de Los Reyes-Garc\u00eda, A.M., Carrillo-Tornel, S., Lozano, M.L., Gonz\u00e1lez-Conejero, R., and Mart\u00ednez, C. (2023). Inflammatory microRNAs in cardiovascular pathology: Another brick in the wall. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1196104"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e70121","DOI":"10.1111\/jcmm.70121","article-title":"Unveiling the therapeutic potential of miR-146a: Targeting innate inflammation in atherosclerosis","volume":"28","author":"Ardinal","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Meng, W.T., Zhu, J., Wang, Y.C., Shao, C.L., Li, X.Y., Lu, P.P., Huang, M.Y., Mou, F.F., Guo, H.D., and Ji, G. (2024). Targeting delivery of miR-146a via IMTP modified milk exosomes exerted cardioprotective effects by inhibiting NF-\u03baB signaling pathway after myocardial ischemia-reperfusion injury. J. Nanobiotechnol., 22.","DOI":"10.1186\/s12951-024-02631-0"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12012-023-09818-1","article-title":"miRNA-146a-5p Inhibits Hypoxia-Induced Myocardial Fibrosis Through EndMT","volume":"24","author":"Wang","year":"2024","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Villagr\u00e1n-Silva, F.A.-O., Loren, P.A.-O., Sandoval, C.A.-O., Lanas, F., and Salazar, L.A.-O. (2025). Circulating microRNAs as Potential Biomarkers of Overweight and Obesity in Adults: A Narrative Review. Genes, 16.","DOI":"10.3390\/genes16030349"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Al-Rawaf, H.A., Gabr, S.A., Alghadir, T., Alghadir, F., Iqbal, A., and Alghadir, A.H. (2025). Correlation between circulating microRNAs and vascular biomarkers in type 2 diabetes based upon physical activity: A biochemical analytic study. BMC Endocr. Disord., 25.","DOI":"10.1186\/s12902-025-01855-x"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Luo, M., Zhao, F., Cheng, H., Su, M., and Wang, Y. (2024). Macrophage polarization: An important role in inflammatory diseases. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1352946"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Gager, G.M., Eyileten, C., Postu\u0142a, M.A.-O., Nowak, A.A.-O., G\u0105secka, A.A.-O., Jilma, B.A.-O., and Siller-Matula, J.A.-O. (2023). Expression Patterns of MiR-125a and MiR-223 and Their Association with Diabetes Mellitus and Survival in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041118"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Blevins, H.M., Xu, Y., Biby, S., and Zhang, S. (2022). The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.879021"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13287-024-04123-2","article-title":"Mesenchymal stem cells derived exosomes: A new era in cardiac regeneration","volume":"16","author":"Sani","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Letonja, J.A.-O., and Petrovi\u010d, D.A.-O. (2024). A Review of MicroRNAs and lncRNAs in Atherosclerosis as Well as Some Major Inflammatory Conditions Affecting Atherosclerosis. Biomedicines, 12.","DOI":"10.3390\/biomedicines12061322"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00125-022-05809-z","article-title":"MicroRNA biomarkers of type 2 diabetes: Evidence synthesis from meta-analyses and pathway modelling","volume":"66","author":"Zhu","year":"2022","journal-title":"Diabetologia"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Hu, F., Liu, L., Liu, Z., Cao, M., Li, G., and Zhang, X. (2023). Meta-analysis of the characteristic expression of circulating microRNA in type 2 diabetes mellitus with acute ischemic cerebrovascular disease. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1129860"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12933-024-02405-w","article-title":"MicroRNAs in diabetic macroangiopathy","volume":"23","author":"Rao","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Wei, Y., Zhu, M., and Schober, A. (2018). Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061756"},{"key":"ref_85","first-page":"200355","article-title":"The role of miR-155 in cardiovascular diseases: Potential diagnostic and therapeutic targets","volume":"24","author":"Zhang","year":"2024","journal-title":"Int. J. Cardiol. Cardiovasc. Risk Prev."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Fitzsimons, S., Oggero, S., Bruen, R., McCarthy, C., Strowitzki, M.J., Mahon, N.G., Ryan, N., Brennan, E.P., Barry, M., and Perretti, M. (2020). microRNA-155 Is Decreased During Atherosclerosis Regression and Is Increased in Urinary Extracellular Vesicles During Atherosclerosis Progression. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.576516"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3892\/etm.2020.9259","article-title":"miR-155 induces endothelial cell apoptosis and inflammatory response in atherosclerosis by regulating Bmal1","volume":"20","author":"Liang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Cerda, A.A.-O., Amaral, A.A., de Oliveira, R., Moraes, T.I., Braga, A.A., Graciano-Saldarriaga, M.E., Fajardo, C.M., Hirata, T.A.-O., Bonezi, V., and Campos-Salazar, A.B. (2021). Peripheral Blood miRome Identified miR-155 as Potential Biomarker of MetS and Cardiometabolic Risk in Obese Patients. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031468"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"17539447241253134","DOI":"10.1177\/17539447241253134","article-title":"Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development","volume":"18","author":"Khalaji","year":"2024","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Li, X., Meng, C., Han, F., Yang, J., Wang, J., Zhu, Y., Cui, X., Zuo, M., Xu, J., and Chang, B. (2021). Vildagliptin Attenuates Myocardial Dysfunction and Restores Autophagy via miR-21\/SPRY1\/ERK in Diabetic Mice Heart. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.634365"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Xu, X., Hong, P., Wang, Z., Tang, Z., and Li, K. (2021). MicroRNAs in Transforming Growth Factor-Beta Signaling Pathway Associated with Fibrosis Involving Different Systems of the Human Body. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.707461"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2147\/JIR.S285714","article-title":"MicroRNA-21 Mediates a Positive Feedback on Angiotensin II-Induced Myofibroblast Transformation","volume":"13","author":"Li","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biopha.2018.03.002","article-title":"MiR-34a-5p mediates sevoflurane preconditioning induced inhibition of hypoxia\/reoxygenation injury through STX1A in cardiomyocytes","volume":"102","author":"Wenlan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Lei, Z., Fang, J., Deddens, J.C., Metz, C.H.G., van Eeuwijk, E.C.M., El Azzouzi, H., Doevendans, P.A., and Sluijter, J.P.G. (2020). Loss of miR-132\/212 Has No Long-Term Beneficial Effect on Cardiac Function After Permanent Coronary Occlusion in Mice. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00590"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/eurheartj\/ehaa967","article-title":"Antagonism of miRNA in heart failure: First evidence in human","volume":"42","author":"Baker","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Fontanella, R.A., Scisciola, L., Marfella, R., Paolisso, G., and Barbieri, M. (2021). Corrigendum: miR-21 in Human Cardiomyopathies. Front. Cardiovasc. Med., 8, Correction in Front. Cardiovasc. Med. 2022, 9, 913429.","DOI":"10.3389\/fcvm.2022.913429"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpha.2019.05.004","article-title":"Research advances in the detection of miRNA","volume":"9","author":"Ye","year":"2019","journal-title":"J. Pharm. Anal."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Siddika, T., and Heinemann, I.U. (2021). Bringing MicroRNAs to Light: Methods for MicroRNA Quantification and Visualization in Live Cells. Front. Bioeng. Biotechnol., 8.","DOI":"10.3389\/fbioe.2020.619583"},{"key":"ref_99","first-page":"207","article-title":"Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: Results of the DEMONSTRATE study","volume":"104","author":"Bernardi","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jmoldx.2023.03.005","article-title":"Preanalytic Methodological Considerations and Sample Quality Control of Circulating miRNAs","volume":"25","author":"Chan","year":"2023","journal-title":"J. Mol. Diagn."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12967-022-03465-w","article-title":"Diagnostic potential of a circulating miRNA model associated with therapeutic effect in heart failure","volume":"20","author":"Qian","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Singh, S., Pathak, A.K., Kural, S., Kumar, L., Bhardwaj, M.G., Yadav, M., Trivedi, S., Das, P., Gupta, M., and Jain, G. (2025). Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-99754-7"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10769\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:14:58Z","timestamp":1762359298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":102,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262110769"],"URL":"https:\/\/doi.org\/10.3390\/ijms262110769","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}